FIELD: medicine. SUBSTANCE: preparation consists of etacridine lactate, trimecaine, essential oil, polyethyleneoxide-400, polyethyleneoxide-1500. The invention provides biological availability. Moreover, the present ointment is of multipurpose therapeutic action being identical to antibiotic- containing ones. EFFECT: a multiple-factor impact. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR TREATING LOCAL PURULENT- INFLAMMATORY PROCESSES OF SKIN AND MUCOUS MEMBRANES | 2000 |
|
RU2185148C2 |
AGENT FOR TREATMENT OF SUPPURATIVE-INFLAMMATORY SKIN AND MUCOUS MEMBRANE PROCESS | 1994 |
|
RU2102979C1 |
AGENT FOR TREATMENT OF SUPPURATIVE-INFLAMMATORY SKIN PROCESSES AND MUCOSA OF DIFFERENT ETIOLOGY | 1995 |
|
RU2074710C1 |
METHOD OF VARIOUS SUPPULATIVE-INFLAMMATORY SKIN AND MUCOUS PROCESS TREATMENT | 2005 |
|
RU2326681C2 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2601897C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2013 |
|
RU2542373C1 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2603490C1 |
ANTIBACTERIAL AND NECROLYTIC LOCAL PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367456C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
Authors
Dates
2002-07-20—Published
2000-01-14—Filed